Newsroom

Industry News

29 Dec

Ronald Martell to Join Cytori Therapeutics’ Board of Directors

SAN DIEGO, Dec. 28, 2016 (GLOBE NEWSWIRE) — Cytori Therapeutics, Inc. (CYTX) (“Cytori” or the “Company”) today announced that Ronald A. Martell has joined the Company’s Board of Directors to serve as an independent director, effective December 27, 2016. Mr. Martell has more than 25 years’ experience building and managing unique businesses...

Read more

29 Dec

Intellipharmaceutics to Present at the Biotech Showcase™

TORONTO, Dec. 29, 2016 (GLOBE NEWSWIRE) — Intellipharmaceutics International Inc. (IPCI) (TSX:I) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that the Company is scheduled to present at the annual...

Read more

29 Dec

Nemus Bioscience Announces Preferred Stock Financing

COSTA MESA, CA / ACCESSWIRE / December 29, 2016 / NEMUS Bioscience, Inc. (NMUS) today announced that it entered into a Securities Purchase Agreement with certain purchasers for the sale of up to 1,500 shares of Series D Preferred Stock for gross proceeds of up to $1,500,000. Each share...

Read more

27 Dec

Nephros Receives FDA 510(k) Clearance of HydraGuard(TM) 10″ UltraFilter

RIVER EDGE, NJ–(Marketwired – Dec 27, 2016) – Nephros, Inc. ( OTCQB : NEPH ) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration (“HDF”) system for use with a hemodialysis machine for the treatment of...

Read more

22 Dec

PCG Advisory Group (PCG) Announces Clients Participating During the 9th Annual Biotech Showcase(TM) Event and the 35th Annual J.P. Morgan Healthcare Conference in San Francisco

NEW YORK, NY / ACCESSWIRE / December 22, 2016 / PCG Advisory Group, a New York based leading investor and public relations firm, announces clients that will be participating in industry events around the upcoming J.P. Morgan Healthcare Conference and 9th Annual Biotech Showcase Event, which are taking place...

Read more

21 Dec

PCG Client Availability in San Francisco, CA

PCG Client Availability in San Francisco, CA January 9 – 12, 2017 To Schedule 1×1 Management Meetings, Please Contact: Kirin Smith: ksmith@pcgadvisory.com – 646-863-6519 Adam Holdsworth: adamh@pcgadvisory.com – 646-862-4607 Abeona Therapeutics (NASDAQ: ABEO) $290mn Mcap, ~$75mn cash Clinical stage bio-pharma company developing gene and plasma-based therapies for life-threatening rare genetic diseases Lead programs are adeno-associated virus...

Read more

21 Dec

PixarBio Corporation Establishes the JP Reynolds Research Center in Woburn, MA to Advance In-house Research Portfolio in Epilepsy, Spinal Cord Injury, and Non-Addictive Pain Platform

CAMBRIDGE, Mass.–(BUSINESS WIRE)— PixarBio Corporation, (PXRB) developers of NeuroReleaseTM, a morphine replacement, non-opiate/opioid, non-addictive pain treatment with FDA approval expected in early 2019, announced today that it has established the JP Reynolds Research Center in Woburn, MA to transfer neurological research toward market. The lab will focus on R&D...

Read more

21 Dec

Monster Digital, Inc. Announces Departure of Jon Orban

SIMI VALLEY, CA–(Marketwired – Dec 21, 2016) – Monster Digital, Inc. ( NASDAQ : MSDI ) (“Monster Digital” or the “Company”), which develops, markets and distributes Monster Digital branded products for use in high-performance consumer electronics, mobile products and computing applications, today announced that, due to other time commitments,...

Read more

21 Dec

Intellipharmaceutics Announces Issuance of U.S. and Canadian Patents Covering Aspects of its PODRAS™ Overdose Technology

TORONTO, Dec. 21, 2016 (GLOBE NEWSWIRE) — Intellipharmaceutics International Inc. (IPCI) (TSX:I) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that U.S. Patent No. 9,522,119 and Canadian Patent No. 2,910,865 were...

Read more

Page 30 of 234« First...1020...2829303132...405060...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address